A meta-analysis of 956 ovarian cancer patients from 8 independent studies demonstrated that tumor-derived MMP-2 expression can predict a lower overall survival rate and could be used as an independent negative prognostic factor [183]. This evidence concerns the gene MMP2 and ovarian cancer.